We become the most trusted partner of our customers and make a better life for patients
Pipeline
KP-FR
Program Target
VEGF, FGF
Disease Indication
Subretinal Fibrosis
Subretinal fibrosis a wound healing response that follows CNV in wet AMD most cases of the severe vision loss in the late stage of AMD leading to permanent photoreceptor damage and vision loss
KP-FR mechanism
KP-FR Novel VEGF/FGF blocking Fc fusion protein A new anti-subretinal fibrosis drug potential First–in-Class Product
PHONE
031-8025-6901
FAX
031-888-6699
Copyright 2021 KPBioscience. All right reserved.
Privacy | service | Contact us
